Chlamydia Rapid Test
-
Where is the price?
Pricing is based on shipping location and the number of units ordered. To request a price, please use the Request a Quote button below. A sales representative will respond to you quickly.
Early diagnosis of Chlamydia trachomatis infection is essential to reduce transmission, support timely treatment, and prevent long-term reproductive health complications. This rapid diagnostic test enables healthcare professionals to make clinical decisions during the patient visit without waiting for laboratory processing.
The Problem: Early Detection of Chlamydia Infection
Chlamydia is the most common sexually transmitted bacterial pathogen that can cause permanent damage to a women’s reproductive system, making pregnancy more difficult and more dangerous. Pregnant women with chlamydia hold a higher risk for birth complications. These include miscarriage, premature birth, and stillbirth. The disease can also be transmitted vertically during birth. Common symptoms of chlamydia include pain when urinating, stomach and pelvis pain, unusual vaginal discharge, pain during sex, bleeding after sex and bleeding between periods. At least 70% of infected women are asymptomatic. However, if chlamydia is left untreated, it can spread to the pelvic and cause pelvic inflammatory disease, a major cause of infertility and ectopic pregnancy in women.
The Solution: Rapid Point-of-Care Chlamydia Testing
The Chlamydia rapid test is a convenient antigen-capture immunochromatographic assay for the qualitative detection of Chlamydia trachomatis (C. trachomatis) antigens from urethral/genital swab specimens. It is intended for professional use as an aid in the diagnosis of C. trachomatis infection.
To test, a swab specimen from the urethral/genital area of the patient is collected. The swab is then placed in a micro tube where two types of specimen extraction buffer are added. The swab is then rotated against the tube and discarded. The sample left in the micro tube is then vortexed and a couple drops added into the sample well of the testing device. The test works by detecting the C. trachomatis antigen in the urethral/genital sample as it flows through the assay by first, C. trachomatis antibodies conjugated with colloidal gold that attach to C. trachomatis antigens and provide a “visual tag” for the antigen-antibody-colloidal gold complex and second, by a test zone with immobilized C. trachomatis antibodies that capture the complex, the visual tags producing a visible pink-colored band that is confirmation of the presence of C. trachomatis and a positive result for chlamydia. If there is no pink line, C. trachomatis is not present, indicating a negative result for chlamydia. Results are ready in 10 minutes.
Product Features
- Rapid qualitative detection of Chlamydia trachomatis
- Results available in approximately 10 minutes
- Cassette-based immunochromatographic assay
- Uses urethral or genital swab specimens
- Designed for professional healthcare use
- Suitable for point-of-care testing
- Ideal for low-resource healthcare settings
Clinical Applications
This rapid test is suitable for:
- Sexual health clinics
- Obstetric and gynecology clinics
- Primary healthcare facilities
- Hospital outpatient departments
- Maternal health programs
- STI screening programs
- Community health services
- Low-resource healthcare settings
Not for sale within the United States.
Frequently Asked Questions
What does this test detect?
The test qualitatively detects Chlamydia trachomatis antigens from urethral or genital swab specimens.
How quickly are results available?
Results are available in approximately 10 minutes.
Is this test intended for professional use?
Yes. The test is intended for use by trained healthcare professionals.
Can this test be used in low-resource settings?
Yes. It is designed to support point-of-care testing in both conventional healthcare facilities and low-resource settings.